mFOLFOX6 和FOLFIRI 方案分别一线和二线治疗晚期胃癌疗效对比观察
童刚领， 程勃然， 陈晓秋， 申东兰， 彭安， 王树滨 - 肿瘤防治研究, 2017 - zlfzyj.com
… , 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients
that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen[J]. …
that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen[J]. …
胃癌术后辅助化疗的研究进展# br
刘婉婷， 顾康生 - 临床肿瘤学杂志, 2018 - manu65.magtech.com.cn
… cancer (SAMIT): a phase 3 factorial randomised controlled trial[J]. Lancet Oncol, 2014, 15(8)…
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin …
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin …
[PDF][PDF] 预防奥沙利铂为基础的中致吐化疗方案所致胃肠肿瘤患者恶心和呕吐的现状及危险因素分析
寇芙蓉， 姜丹凤， 张红， 夏丽娜， 刘巍 - 肿瘤, 2021 - tumorsci.org
… The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric … treatment:
agreement between patient and physician reporting in three randomized trials[J]. J Clin …
agreement between patient and physician reporting in three randomized trials[J]. J Clin …
胃癌化疗的现状与研究进展.
赵佳， 王硕， 曲晶磊 - Practical Pharmacy & Clinical …, 2019 - search.ebscohost.com
… main treatment for both postoperative adjuvant therapy for … 伊立替康联合氟尿嘧啶(FOLFIRI)方案
与铂类联合氟尿嘧 啶为基础的… Randomized trial comparing epirubicinꎬ cisplatinꎬ and …
与铂类联合氟尿嘧 啶为基础的… Randomized trial comparing epirubicinꎬ cisplatinꎬ and …
[PDF][PDF] 2019 年胃肠恶性肿瘤研究进展
董秋美， 马冬 - 循证医学, 2020 - jebm.cn
… 昔单抗),双药组(Encorafenib 联合西妥昔单抗) 或对照组(伊立替康或FOLFIRI 联合西妥昔单 抗
).结果发现三药方案对BRAF 突变的mCRC 较标准的化疗靶向联合方案明显延长OS(9.0 个 月vs. …
).结果发现三药方案对BRAF 突变的mCRC 较标准的化疗靶向联合方案明显延长OS(9.0 个 月vs. …
[HTML][HTML] 胃癌辅助治疗的研究进展
李宏伟， 杨金坤， 赵爱光 - 世界华人消化杂志, 2014 - wjgnet.com
… effect of postoperative adjuvant therapy is becoming … therapy and postoperative rehabilitation.
The purpose of this paper is to introduce the progress in postoperative adjuvant therapy for …
The purpose of this paper is to introduce the progress in postoperative adjuvant therapy for …
[HTML][HTML] EOX 与FOLFIRI 方案一线治疗晚期胃癌的疗效比较
李建旺， 黄春珍， 元建华， 陈琼慧 - 世界华人消化杂志, 2016 - wjgnet.com
… in the FOLFIRI group received irinotecan 180 mg/m 2 on day 1, leucovorin 400 mg/m 2 as
two-hour infusion and 5-fluorouracil 400 mg/m 2 as a bolus, on day 1 and day 2 followed by …
two-hour infusion and 5-fluorouracil 400 mg/m 2 as a bolus, on day 1 and day 2 followed by …
[PDF][PDF] 可切除的局部进展期胃癌及转移性胃癌治疗现状及进展
廖孝枫， 刘合利， 刘鹏 - 中南大学学报(医学版), 2020 - jcme.org.cn
… Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin
versus 5-fluorouracil and folinic acid for radically resected gastric cancer[J]. Ann Oncol, 2014, …
versus 5-fluorouracil and folinic acid for radically resected gastric cancer[J]. Ann Oncol, 2014, …
[PDF][PDF] 2013 NCCN 胃癌临床实践指南(2013. V2) 要点介绍及解读
郭仁宏 - 中国医学前沿杂志(电子版), 2013 - medi-guide.meditool.cn
… Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative
gastric cancer: a randomised trial. … Second-line chemotherapy with FOLFIRI in patients with …
gastric cancer: a randomised trial. … Second-line chemotherapy with FOLFIRI in patients with …
[HTML][HTML] 晚期胰腺癌的化疗进展
徐玲， 刘云鹏 - 世界华人消化杂志, 2010 - wjgnet.com
胰腺癌在诊断时多数为晚期, 采用以化疗为主的综合治疗. 吉西他滨仍然是化疗的标准用药,
吉西他滨为基础的联合治疗取得了一定的疗效, 靶向药物的应用使优势人群的疗效进一步提高. 本文…
吉西他滨为基础的联合治疗取得了一定的疗效, 靶向药物的应用使优势人群的疗效进一步提高. 本文…